We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Celldex Therapeutics, a biotechnology company focusing on the treatment of cancer,
infectious disease and immune system disorders, set its planned initial public
offering at 4 million shares for between $8 and $10 per share.
Quintiles Transnational said it is joining two other organizations to establish
a $112 million fund to buy pharmaceutical products for the Asia Pacific market.
Singapore's state investment arm said it has entered a joint venture with U.S.
biotechnology giant Quintiles Transnational Corporation and Hong Kong-based
health care company Interpharma Asia Pacific to sell drugs in the Asia-Pacific
region.
The Pharmaceuticals Control Bureau, alerted by the Chinese authorities, has
asked relevant agencies to stop the import, trading and circulation of 25 types
of medicines from China, which have also been banned in their country of origin.
PharmaDesign announced on June
8 that it has concluded a non-exclusive licensing agreement with Daiichi Pharmaceutical
for Admensa Interactive, a suite of predictive drug absorption, distribution,
metabolism and excretion (ADME) models and compound prioritization tools developed
and provided by UK company Inpharmatica.